Chicago, IL - 2015 ASCO Annual Meeting - Luis Paz-Ares, MD, PhD, presenting abstract LBA109, Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC) during "Immunotherapy for Every Patient: Check Your Enthusiasm" Clinical Science Symposium at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday, May 30, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Max Gersh 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org
Chicago, IL - 2015 ASCO Annual Meeting - General views at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Saturday, May 30, 2015. Over 30,000 physicians, researchers and healthcare professionals from over 100 countries are attending the 51st Annual Meeting which is being held at the McCormick Place convention center. The Annual Meeting highlights the latest findings in all major areas of oncology from basic through clinical and epidemiological studies. Photo by © ASCO/Rodney White 2015 Technical Questions: todd@toddbuchanan.com; ASCO Contact: photos@asco.org
